ARDL was key player in GRADE Study
LMP’s Advanced Research and Diagnostic Laboratory (ARDL) was the Central Biochemistry Laboratory for the Glycemic Reduction Approaches in Diabetes (GRADE).
LMP’s Advanced Research and Diagnostic Laboratory (ARDL) was the Central Biochemistry Laboratory for the Glycemic Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE), a clinical trial conducted from 2013-2021 studying the effectiveness of different treatments for type 2 diabetes. The NIH press release and the New England Journal of Medicine paper below reflect the consistent and excellent performance of all those working in ARDL.
